The AI Forecasting Gap: What's Holding the Industry Back and What's Actually Working
If your forecasting process still runs on spreadsheets, manual assumption-gathering, and tribal knowledge, you're in good company. According to Axtria's 2026 Life Sciences Forecasting Benchmarking Report, 82% of pharma organizations have yet to apply AI to a single core forecasting assumption, even as AI tops every forecasting team's priority list.
This webinar brings together Axtria's 2026 benchmarking data and a seasoned forecasting practitioner to examine that paradox from the inside. The conversation is grounded in the actual constraints forecasters work with: small teams, complex stakeholder environments, analog comparisons, and assumptions that live in email threads and meeting notes. You can’t engineer around these; they're the core of the function. But they're precisely where GenAI has the most to offer.
Attendees will come away with a clear read on where the industry stands, where AI entry points exist that don't require rebuilding existing workflows from scratch, and what it takes to move forward with organizational confidence.
Author details
Eric Haskel
Business Planning & Capabilities Director at AstraZeneca
Jeff Olive
Forecasting Principal at Axtria